A Simultaneous D-Optimal Designed Study for Population Pharmacokinetic Analyses of Mycophenolic Acid and Tacrolimus Early After Renal Transplantation-Reference-Cited by-同舟云学术

A Simultaneous D-Optimal Designed Study for Population Pharmacokinetic Analyses of Mycophenolic Acid and Tacrolimus Early After Renal Transplantation

Published:2012-12 Issue:12 Volume:52 Page:1833-1843
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Musuamba Flora Tshinanu,Mourad Michel,Haufroid Vincent,Demeyer Martine,Capron Arnaud,Delattre Isabelle K.,Delaruelle Frederic,Wallemacq Pierre,Verbeeck Roger Karel

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1177/0091270011423661/fullpdf

Reference28 articles.

1. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients;Staatz;Clin Pharmacokinet,2007

2. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation;Staatz;Clin Pharmacokinet,2004

3. Limited sampling models and Bayesian estimation for mycophenolic acid area under the curve prediction in stable renal transplant patients comedicated with ciclosporin or sirolimus;Musuamba;Clin Pharmacokinet,2009

4. Time of drug administration, CYP3A5 and ABCB1 genotypes and analytical method influence tacrolimus pharmacokinetics: a population pharmacokinetic study;Musuamba;Ther Drug Monit,2009

5. Population pharmacokinetics of tacrolimus in adult kidney transplant recipients;Staatz;Clin Phamacol Ther,2002

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population pharmacokinetics study of tacrolimus in liver transplant recipients: a comparison between patients with or without liver cancer before surgery;Frontiers in Pharmacology;2024-08-23

2. Dosage optimization of tacrolimus based on the glucocorticoid dose and pharmacogenetics in adult patients with systemic lupus erythematosus;International Immunopharmacology;2023-11

3. Individualization of Mycophenolic Acid Therapy through Pharmacogenetic, Pharmacokinetic and Pharmacodynamic Testing;Biomedicines;2022-11-10

4. Recent lessons learned from population pharmacokinetic studies of mycophenolic acid: physiological, genomic, and drug interactions leading to the prediction of drug effects;Expert Opinion on Drug Metabolism & Toxicology;2021-12-02

5. Estimation of Mycophenolic Acid Exposure in Heart Transplant Recipients by Population Pharmacokinetic and Limited Sampling Strategies;Frontiers in Pharmacology;2021-11-19